AMN Healthcare Services (AMN) AI Stock Analysis

• Market Cap: $614.24M
• Dividend Yield: N/A
• Average Volume (3M): 1.08M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.56
• Revenue Growth: -11.42%
• EPS Growth: -617.31%
• Country: US
• Employees: 2,968
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 0.39
• Shares Outstanding: 38,413,780
• 10 Day Avg. Volume: 1,123,068
• 30 Day Avg. Volume: 1,078,270
• PEG Ratio: 0.04
• Price to Book (P/B): 1.29
• Price to Sales (P/S): 0.31
• P/FCF Ratio: 3.81
• Enterprise Value/Market Cap: 2.54
• Enterprise Value/Revenue: 0.57
• Enterprise Value/Gross Profit: 2.05
• Enterprise Value/Ebitda: -14.83
• 1Y Price Target: $21.50
• Price Target Upside: 34.46% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 7
• EPS Forecast (FY): 1.41
• Revenue Forecast (FY): $2.71B

• Rating: 50 Neutral
• Price Target: $16.50 ▲(3.19% Upside)

AMN Healthcare Services' overall stock score reflects challenges in financial performance and technical analysis, with a negative P/E ratio and no dividend yield. Positive earnings call highlights and strategic corporate events provide some support, but the stock remains under pressure due to operational and market challenges.

Positive Factors

Debt Refinancing

Refinancing extends debt maturities, enhances financial flexibility, and supports long-term growth by improving the corporate debt rating.

Client Satisfaction Improvement

Improved client satisfaction can lead to higher client retention and increased revenue opportunities, strengthening market position.

Revenue Above Guidance

Exceeding revenue guidance indicates strong demand and effective execution, suggesting potential for sustained revenue growth.

Negative Factors

Declining Revenue

Declining revenue trends can indicate market challenges or competitive pressures, potentially impacting long-term growth prospects.

High Leverage

High leverage can strain financial flexibility and increase risk, necessitating focus on debt reduction for improved stability.

Gross Margin Decline

Declining gross margins may reduce profitability and indicate challenges in maintaining pricing power or cost control.

AMN Healthcare Services Business Overview & Revenue Model

Company Description

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, telehealth, credentialing, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, and Merritt Hawkins, as well as AMN Revenue Cycle Solutions and AMN Language Services. The company was founded in 1985 and is based in Dallas, Texas.

How the Company Makes Money

AMN Healthcare generates revenue primarily through the provision of staffing services, which include placing nurses, physicians, and allied health professionals in temporary and permanent positions within healthcare facilities. The company operates on a fee-for-service model, charging clients a markup on the hourly rates paid to the healthcare professionals it places. Key revenue streams include travel nursing, where AMN contracts with healthcare facilities to provide nurses for short-term assignments, and locum tenens services, where it supplies temporary physicians to fill gaps in staffing. Additionally, AMN benefits from consulting services and technology solutions that help healthcare organizations manage their workforce more efficiently. Strategic partnerships with healthcare providers and technology firms enhance AMN's offerings, contributing to its revenue growth.

AMN Healthcare Services Financial Statement Overview

Summary

AMN Healthcare Services faces challenges with declining revenue and profitability, high leverage, and reduced cash flow efficiency. The company needs to implement strategies to improve operational efficiency, reduce debt, and enhance cash flow generation to stabilize its financial position and support future growth.

Income Statement

AMN Healthcare Services has experienced declining revenue and profitability over recent periods. The TTM data shows negative net profit and EBIT margins, indicating operational challenges. Revenue has decreased by 1.91% in the TTM period, following a trend of declining revenue growth. The company needs to address its cost structure to improve profitability.

Balance Sheet

The company's balance sheet shows a high debt-to-equity ratio of 1.31 in the TTM period, indicating significant leverage. Return on equity is negative, reflecting the net losses. However, the equity ratio remains stable, suggesting a reasonable proportion of equity financing. The company should focus on reducing debt to improve financial stability.

Cash Flow

Cash flow from operations remains positive, but free cash flow has declined by 12.79% in the TTM period. The operating cash flow to net income ratio is below 1, indicating that cash generation is not fully covering net losses. The company needs to enhance cash flow efficiency to support operations and reduce reliance on external financing.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.72B	2.98B	3.79B	5.24B	3.98B	2.39B
Gross Profit	760.54M	919.38M	1.25B	1.72B	1.31B	791.78M
EBITDA	-105.30M	71.11M	499.36M	784.21M	581.70M	243.45M
Net Income	-275.54M	-146.98M	210.68M	444.05M	327.39M	70.67M
Balance Sheet
Total Assets	2.14B	2.42B	2.92B	2.89B	3.13B	2.35B
Cash, Cash Equivalents and Short-Term Investments	52.64M	10.65M	32.94M	64.52M	180.93M	29.21M
Total Debt	884.90M	1.10B	1.35B	860.96M	867.07M	955.48M
Total Liabilities	1.49B	1.71B	2.09B	1.84B	1.97B	1.53B
Stockholders Equity	644.41M	706.62M	831.26M	1.04B	1.16B	819.68M
Cash Flow
Free Cash Flow	222.80M	239.53M	266.78M	572.81M	251.69M	217.72M
Operating Cash Flow	266.70M	320.42M	372.17M	653.73M	305.36M	256.83M
Investing Cash Flow	-1.85M	-79.94M	-412.49M	-170.71M	-107.40M	-538.17M
Financing Cash Flow	-292.55M	-259.45M	10.73M	-591.87M	-34.90M	211.49M

AMN Healthcare Services Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 15.99
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMN, the sentiment is Negative. The current price of 15.99 is below the 20-day moving average (MA) of 16.40, below the 50-day MA of 17.76, and below the 200-day MA of 19.86, indicating a bearish trend. The MACD of -0.40 indicates Negative momentum. The RSI at 42.12 is Neutral, neither overbought nor oversold. The STOCH value of 38.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AMN.

AMN Healthcare Services Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HCSG	72 Outperform	$1.38B	36.23	8.07%	―	6.26%	-19.33%
AVAH	58 Neutral	$1.82B	24.17	―	―	15.48%	―
ASTH	56 Neutral	$1.23B	128.63	1.29%	―	68.17%	-85.42%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AMN	50 Neutral	$614.24M	-2.22	-35.90%	―	-11.42%	-617.31%
CCRN	48 Neutral	$261.10M	-16.50	-3.76%	―	-22.14%	-787.87%
MODVQ	45 Neutral	$430.62K	>-0.01	―	―	-0.70%	-2.38%

AMN Healthcare Services Corporate Events

AMN Healthcare Updates Bylaws for Governance Efficiency

On December 11, 2025, AMN Healthcare Services‘ Board of Directors approved new by-laws to align with Delaware law, revise procedural mechanics for stockholder meetings, and update director nomination processes. These changes, effective immediately, aim to enhance governance and operational efficiency, impacting how stockholder meetings and director nominations are conducted.

AMN Healthcare Issues $400M Senior Notes for Refinancing

On October 6, 2025, AMN Healthcare, Inc., a subsidiary of AMN Healthcare Services, Inc., issued $400 million in 6.500% Senior Notes due in 2031. This issuance, part of a strategic financial maneuver, is aimed at refinancing existing debt and optimizing the company’s capital structure. Concurrently, the company amended its existing credit agreement, reducing its revolving credit facility from $750 million to $450 million and extending its maturity to 2030. These actions are expected to enhance financial flexibility and support the company’s long-term growth objectives.

AMN Healthcare Announces $400M Senior Notes Offering

On September 22, 2025, AMN Healthcare announced an unregistered offering of $400 million in senior unsecured notes due 2031, with the proceeds intended to redeem $500 million of notes due 2027 and cover related expenses. This strategic financial move aims to optimize the company’s debt structure, potentially enhancing its financial flexibility and market positioning.

AMN Healthcare Services Amends Credit Agreement Terms

AMN Healthcare Services announced plans to amend its existing Credit Agreement, originally dated February 9, 2018. The amendment will extend the maturity of its revolving credit facility to October 2030, reduce its size from $750 million to $450 million, and adjust the credit spread and leverage ratio terms. The final documentation for this amendment is expected to be executed in the fourth quarter of 2025, potentially impacting the company’s financial flexibility and operational strategy.